» Articles » PMID: 20186458

A 629RKLKK633 Motif in the Hinge Region Controls the Androgen Receptor at Multiple Levels

Overview
Publisher Springer
Specialty Biology
Date 2010 Feb 27
PMID 20186458
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The androgen receptor protein has specific domains involved in DNA binding, ligand binding, and transactivation, whose activities need to be integrated during transcription activation. The hinge region, more particular a (629)RKLKK(633) motif, seems to play a crucial role in this process. Indeed, although the motif is not part of the DNA-binding domain, its positive residues are involved in optimal DNA binding and nuclear translocation as shown by mutation analysis. When the mutated ARs are forced into the nucleus, however, the residues seem to play different roles in transactivation. Moreover, we show by FRAP analysis that during activation, the AR is distributed in the nucleus in a mobile and two immobile fractions, and that mutations in the (629)RKLKK(633) motif affect the distribution of the AR over these three intranuclear fractions. Taken together, the (629)RKLKK(633) motif is a multifunctional motif that integrates nuclear localization, receptor stability, DNA binding, transactivation potential and intranuclear mobility.

Citing Articles

RNA fine-tunes estrogen receptor-alpha binding on low-affinity DNA motifs for transcriptional regulation.

Soota D, Saravanan B, Mann R, Kharbanda T, Notani D EMBO J. 2024; 43(21):5186-5210.

PMID: 39284910 PMC: 11535219. DOI: 10.1038/s44318-024-00225-y.


Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.

Helsen C, Rocca M, Nguyen T, Eerlings R, Lee X, De Block S Protein Sci. 2023; 32(4):e4599.

PMID: 36806291 PMC: 10019450. DOI: 10.1002/pro.4599.


The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2.

Helsen C, Nguyen T, Vercruysse T, Wouters S, Daelemans D, Voet A Int J Mol Sci. 2022; 23(3).

PMID: 35163481 PMC: 8836279. DOI: 10.3390/ijms23031557.


Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Arnold F, Merry D Neurotherapeutics. 2019; 16(4):928-947.

PMID: 31686397 PMC: 6985201. DOI: 10.1007/s13311-019-00790-9.


Impact of taxanes on androgen receptor signaling.

Bai S, Zhang B, Dong Y Asian J Androl. 2018; 21(3):249-252.

PMID: 29900882 PMC: 6498725. DOI: 10.4103/aja.aja_37_18.


References
1.
Dinant C, Luijsterburg M, Hofer T, von Bornstaedt G, Vermeulen W, Houtsmuller A . Assembly of multiprotein complexes that control genome function. J Cell Biol. 2009; 185(1):21-6. PMC: 2700518. DOI: 10.1083/jcb.200811080. View

2.
Fu M, Wang C, Reutens A, Wang J, Angeletti R, Ogryzko V . p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem. 2000; 275(27):20853-60. DOI: 10.1074/jbc.M000660200. View

3.
Chen S, Kesler C, Paschal B, Balk S . Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1. J Biol Chem. 2009; 284(38):25576-84. PMC: 2757959. DOI: 10.1074/jbc.M109.043133. View

4.
Deeb A, Jaaskelainen J, Dattani M, Whitaker H, Costigan C, Hughes I . A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions. J Clin Endocrinol Metab. 2008; 93(10):3691-6. DOI: 10.1210/jc.2008-0737. View

5.
Verrijdt G, Haelens A, Schoenmakers E, Rombauts W, Claessens F . Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem J. 2001; 361(Pt 1):97-103. PMC: 1222283. DOI: 10.1042/0264-6021:3610097. View